Pascal Biosciences Inc (PAS)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Pascal Biosciences Inc (PAS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014299
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Pascal Biosciences Inc (Pascal Biosciences), formerly BioMmune Technologies Inc is a biopharmaceutical company that offers discovery and development of new therapeutics that enable the body’s immune system . The company advances technologies which can control the immune activity and improve their ability to attack cancers, infections and autoimmune diseases. Its research programs comprise Major Histocompatibility Complex I, that restores the immune system’s ability to recognize and destroy cancer cells. Pascal Biosciences offers research on calcium channel blockers that modulates voltage-gated calcium channels for the signalling of immune system response and prevents transplant rejection. The company also provides CD74, a chaperone protein that aids the immune system to combat infections and cancers. Pascal Biosciences is headquartered in Vancouver, British Columbia, Canada.

Pascal Biosciences Inc (PAS) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Biommune Enters into Agreement with University of British Columbia 10
Licensing Agreements 11
Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11
Equity Offering 12
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 12
BioMmune Raise USD0.8 Million in Private Placement of Units 13
Acquisition 14
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 14
Pascal Biosciences Inc – Key Competitors 15
Pascal Biosciences Inc – Key Employees 16
Pascal Biosciences Inc – Locations And Subsidiaries 17
Head Office 17
Recent Developments 18
Strategy And Business Planning 18
May 09, 2017: Pascal Biosciences Creates Development Science Lab in Seattle WA 18
Corporate Communications 19
Sep 20, 2016: BioMmune Appoints Thomas Gadek, PhD, to Board of Directors 19
Apr 22, 2016: BioMmune Appoints Dr. Patrick Gray as New Chief Executive Officer and President 20
Other Significant Developments 21
Mar 30, 2017: bioMmune Announces Name Change to Pascal Biosciences 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Pascal Biosciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Pascal Biosciences Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Pascal Biosciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Biommune Enters into Agreement with University of British Columbia 10
Pascal Biosciences Enters into Licensing Option Agreement with STC.UNM 11
BioMmune Technologies Raises USD0.4 Million in Private Placement of Units 12
BioMmune Raise USD0.8 Million in Private Placement of Units 13
MC Partners Acquires bioMmune Advanced Technologies in Reverse Takeover Transaction 14
Pascal Biosciences Inc, Key Competitors 15
Pascal Biosciences Inc, Key Employees 16

★海外企業調査レポート[Pascal Biosciences Inc (PAS)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Black Box Corp (BBOX):企業の財務・戦略的SWOT分析
    Black Box Corp (BBOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Iamgold Corporation:企業の戦略・SWOT・財務情報
    Iamgold Corporation - Strategy, SWOT and Corporate Finance Report Summary Iamgold Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Prognomix Inc:企業の製品パイプライン分析
    Summary Prognomix Inc (Prognomix) is a personalized medicine company that develops molecular diagnostic test for detection of risks to develop renal, ocular, cardiac, cerebral, vascular and other complications of diabetic disease. The company’s products include PGX IR01, PGx GR01, PGx CD01, PGx IR02 …
  • Duro Felguera SA (MDF):企業の財務・戦略的SWOT分析
    Duro Felguera SA (MDF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • MIS Implants Technologies Ltd:医療機器:M&Aディール及び事業提携情報
    Summary MIS Implants Technologies Ltd (MIS) is a medical device company that offers advanced products and solutions for dental implantology treatment. The company offers products such as superstructures, dental implants, tools and kits, and solutions for oral restoration and health, among others. It …
  • Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析
    Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gas Sensing Technology Corp:石油・ガス:M&Aディール及び事業提携情報
    Summary Gas Sensing Technology Corp (Gas Sensing Technology), doing business as Welldog, a subsidiary of The Blue Sky Group Inc, is oil and gas company that provides technologies and reservoir analysis services. The company offers shale oil and gas, coal seam gas, coal mining, conventional oil and g …
  • Okamoto Industries, Inc.:企業の戦略・SWOT・財務分析
    Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Okamoto Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Vistin Pharma AS (VISTIN)-製薬・医療分野:企業M&A・提携分析
    Summary Vistin Pharma AS (Vistin), a subsidiary of Vistin Pharma ASA is a healthcare company that produces and supplies solid dosage forms and active pharmaceutical ingredients. The company’s products include metformin, an API for the treatment of diabetes II; opioids, an analgesics and antitussive; …
  • ATI Physical Therapy:製薬・医療:M&Aディール及び事業提携情報
    Summary ATI Physical Therapy (ATI) is a healthcare service provider that offers therapy and healthcare services. The center offers therapy services such as hand therapy, women's health, workers' comp rehab, sports therapy, physical therapy, specialty therapies, home health and complimentary injury s …
  • Vesteda Group:企業の戦略・SWOT・財務情報
    Vesteda Group - Strategy, SWOT and Corporate Finance Report Summary Vesteda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Advanced Emissions Solutions, Inc. (ADES):企業の財務・戦略的SWOT分析
    Advanced Emissions Solutions, Inc. (ADES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Screen Holdings Co., Ltd. (7735):企業の財務・戦略的SWOT分析
    Screen Holdings Co., Ltd. (7735) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Tidewater Inc (TDW):企業の財務・戦略的SWOT分析
    Summary Tidewater Inc (Tidewater) is an an petroleum service company that offers offshore supply vessels and marine support services. The company's services include transport and supply of offshore material; anchor handling, towing and positioning; personnel support; and assistance, salvage and reme …
  • Manitou Bf Sa
    Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report Summary Manitou Bf Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ems-Chemie Holding AG (EMSN):企業の財務・戦略的SWOT分析
    Summary Ems-Chemie Holding AG (Ems-Chemie), a subsidiary of Emesta Holding AG, is a chemical company. The company manufactures and markets high performance polymers and specialty chemicals. Its products include bonding products, polyamides, damping systems, sealants, and coating products. Ems-Chemie …
  • Enable Injections Inc:医療機器:M&Aディール及び事業提携情報
    Summary Enable Injections Inc (Enable Injections) is a medical device company that manufactures and develops disposable body-worn bolus injector to deliver high viscosity payloads to the subcutaneous tissue. The company develops delivery device, delivery systems, and injector systems including vial …
  • Astex Pharmaceuticals Inc:企業の戦略的SWOT分析
    Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • AIA Bhd:企業の戦略・SWOT・財務情報
    AIA Bhd - Strategy, SWOT and Corporate Finance Report Summary AIA Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Algonquin Power & Utilities Corp:発電所・企業SWOT分析
    Algonquin Power & Utilities Corp - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆